|
|
|
FIN 2012
COI 1.64 %
*
Breed relevant health information:
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
-
21/1/2014
|
|
|||
|
|
||
|
|||
DNK 2017
COI 3.13 %
*
Breed relevant health information:
Degenerative myelopathy (DM)
N/mut (carrier)
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Moderate / D1 / 19-30 / D / 36-50
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
Result of general cardiovascular health checks
OK
|
DNK 2013
COI 0.96 %
*
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
|
DNK 2008
COI 0.88 %
*
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
Year of death:
2021
Cause of death:
Liver failure
|
|||
DNK 2014
COI 1.35 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
DNK 2011
COI 0.48 %
*
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
Year of death:
2023
Cause of death:
Old age (unspecified cause of death)
Myelomatose
|
||
DNK 2010
COI 1.73 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
Year of death:
2024
Cause of death:
Old age (unspecified cause of death)
Old age
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Shacal Tulenarka
|
20 Dec 2015 | |||||||||
Happy Lapp Jasmin
|
27 May 2017 | N/mut (carrier) | N/N (clear) | Moderate / D1 / 19-30 / D / 36-50 | N/mut (carrier) | OK | ||||
Degenerative myelopathy (DM):
N/mut (carrier)
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Moderate / D1 / 19-30 / D / 36-50
Progressive retinal atrophy (prcd-PRA):
N/mut (carrier)
Result of general cardiovascular health checks:
OK
|
||||||||||
Siblings | ||||||||||
Happy Lapp Taito
|
28 Nov 2020 | N/N (clear) | normal | N/N (clear) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | N/N (clear) | ||||
Degenerative myelopathy (DM):
N/N (clear)
Elbows:
normal
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Happy Lapp Tulitikkutyttö
|
28 Nov 2020 | N/N (clear) | N/mut (carrier) | normal | N/N (clear) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | N/N (clear) | |||
Canine Multifocal Retinopathy 3 (CMR3):
N/N (clear)
Degenerative myelopathy (DM):
N/mut (carrier)
Elbows:
normal
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Happy Lapp Tupsu
|
28 Nov 2020 | |||||||||
Half siblings (sire) | ||||||||||
Barffas Xankari
|
28 Jul 2018 | |||||||||
Barffas Xilmu
|
28 Jul 2018 | |||||||||
Barffas Xitruuna
|
28 Jul 2018 | |||||||||
Barffas Xuper
|
28 Jul 2018 | |||||||||
Barffas Xuukko
|
28 Jul 2018 | |||||||||
Barffas Xuuruus
|
28 Jul 2018 | |||||||||
Taivaannastan Havis Amanda
|
27 Apr 2019 | |||||||||
Alisa Freindlix
|
21 May 2022 | |||||||||
Feya Tinker Bell
|
21 May 2022 | |||||||||
Fleur Delacour
|
21 May 2022 | |||||||||
Formula Ljubvi
|
21 May 2022 | |||||||||
Frau Chiffa
|
21 May 2022 | |||||||||
Violet Montmartre
|
21 May 2022 | |||||||||
Half siblings (dam) | ||||||||||
Offspring |